Global Omics Based Clinical Trials Market Research Report 2023

Omics is a rapidly evolving, multi-disciplinary, and emerging field that encompasses genomics, epigenomics, transcriptomics, proteomics, and metabolomics.Advanced omics technologies, including single-cell omics and multi-omics, are being used to evaluate a variety of cancer immunotherapies. Furthermore, given the precision medicine environment, the expanding use of multi-omics in research, as well as the penetration of contemporary sequencing technologies, is boosting the market.

The global Omics Based Clinical Trials market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Omics Based Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Omics Based Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Omics Based Clinical Trials in Oncology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Omics Based Clinical Trials include Parexel International Corporation, Pharmaceutical Product Development (PPD), Charles River Laboratory, ICON plc, SGS SA, Eli Lilly and Company, Pfizer, Covance and Rebus Bio, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Omics Based Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omics Based Clinical Trials.

The Omics Based Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Omics Based Clinical Trials market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Omics Based Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Omics Based Clinical Trials Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Interventional Studies

1.2.3 Observational Studies

1.2.4 Expanded Access Studies

1.3 Market by Application

1.3.1 Global Omics Based Clinical Trials Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Respiratory Diseases

1.3.5 Skin Diseases

1.3.6 CNS Diseases

1.3.7 Immunology

1.3.8 Genetic Diseases

1.3.9 Other Indications

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Omics Based Clinical Trials Market Perspective (2018-2029)

2.2 Omics Based Clinical Trials Growth Trends by Region

2.2.1 Global Omics Based Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Omics Based Clinical Trials Historic Market Size by Region (2018-2023)

2.2.3 Omics Based Clinical Trials Forecasted Market Size by Region (2024-2029)

2.3 Omics Based Clinical Trials Market Dynamics

2.3.1 Omics Based Clinical Trials Industry Trends

2.3.2 Omics Based Clinical Trials Market Drivers

2.3.3 Omics Based Clinical Trials Market Challenges

2.3.4 Omics Based Clinical Trials Market Restraints

3.1 Global Top Omics Based Clinical Trials Players by Revenue

3.1.1 Global Top Omics Based Clinical Trials Players by Revenue (2018-2023)

3.1.2 Global Omics Based Clinical Trials Revenue Market Share by Players (2018-2023)

3.2 Global Omics Based Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Omics Based Clinical Trials Revenue

3.4 Global Omics Based Clinical Trials Market Concentration Ratio

3.4.1 Global Omics Based Clinical Trials Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Omics Based Clinical Trials Revenue in 2022

3.5 Omics Based Clinical Trials Key Players Head office and Area Served

3.6 Key Players Omics Based Clinical Trials Product Solution and Service

3.7 Date of Enter into Omics Based Clinical Trials Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Omics Based Clinical Trials Historic Market Size by Type (2018-2023)

4.2 Global Omics Based Clinical Trials Forecasted Market Size by Type (2024-2029)

5.1 Global Omics Based Clinical Trials Historic Market Size by Application (2018-2023)

5.2 Global Omics Based Clinical Trials Forecasted Market Size by Application (2024-2029)

6.1 North America Omics Based Clinical Trials Market Size (2018-2029)

6.2 North America Omics Based Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Omics Based Clinical Trials Market Size by Country (2018-2023)

6.4 North America Omics Based Clinical Trials Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Omics Based Clinical Trials Market Size (2018-2029)

7.2 Europe Omics Based Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Omics Based Clinical Trials Market Size by Country (2018-2023)

7.4 Europe Omics Based Clinical Trials Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Omics Based Clinical Trials Market Size (2018-2029)

8.2 Asia-Pacific Omics Based Clinical Trials Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Omics Based Clinical Trials Market Size by Region (2018-2023)

8.4 Asia-Pacific Omics Based Clinical Trials Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Omics Based Clinical Trials Market Size (2018-2029)

9.2 Latin America Omics Based Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Omics Based Clinical Trials Market Size by Country (2018-2023)

9.4 Latin America Omics Based Clinical Trials Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Omics Based Clinical Trials Market Size (2018-2029)

10.2 Middle East & Africa Omics Based Clinical Trials Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Omics Based Clinical Trials Market Size by Country (2018-2023)

10.4 Middle East & Africa Omics Based Clinical Trials Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Parexel International Corporation

11.1.1 Parexel International Corporation Company Detail

11.1.2 Parexel International Corporation Business Overview

11.1.3 Parexel International Corporation Omics Based Clinical Trials Introduction

11.1.4 Parexel International Corporation Revenue in Omics Based Clinical Trials Business (2018-2023)

11.1.5 Parexel International Corporation Recent Development

11.2 Pharmaceutical Product Development (PPD)

11.2.1 Pharmaceutical Product Development (PPD) Company Detail

11.2.2 Pharmaceutical Product Development (PPD) Business Overview

11.2.3 Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Introduction

11.2.4 Pharmaceutical Product Development (PPD) Revenue in Omics Based Clinical Trials Business (2018-2023)

11.2.5 Pharmaceutical Product Development (PPD) Recent Development

11.3 Charles River Laboratory

11.3.1 Charles River Laboratory Company Detail

11.3.2 Charles River Laboratory Business Overview

11.3.3 Charles River Laboratory Omics Based Clinical Trials Introduction

11.3.4 Charles River Laboratory Revenue in Omics Based Clinical Trials Business (2018-2023)

11.3.5 Charles River Laboratory Recent Development

11.4 ICON plc

11.4.1 ICON plc Company Detail

11.4.2 ICON plc Business Overview

11.4.3 ICON plc Omics Based Clinical Trials Introduction

11.4.4 ICON plc Revenue in Omics Based Clinical Trials Business (2018-2023)

11.4.5 ICON plc Recent Development

11.5 SGS SA

11.5.1 SGS SA Company Detail

11.5.2 SGS SA Business Overview

11.5.3 SGS SA Omics Based Clinical Trials Introduction

11.5.4 SGS SA Revenue in Omics Based Clinical Trials Business (2018-2023)

11.5.5 SGS SA Recent Development

11.6 Eli Lilly and Company

11.6.1 Eli Lilly and Company Company Detail

11.6.2 Eli Lilly and Company Business Overview

11.6.3 Eli Lilly and Company Omics Based Clinical Trials Introduction

11.6.4 Eli Lilly and Company Revenue in Omics Based Clinical Trials Business (2018-2023)

11.6.5 Eli Lilly and Company Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Omics Based Clinical Trials Introduction

11.7.4 Pfizer Revenue in Omics Based Clinical Trials Business (2018-2023)

11.7.5 Pfizer Recent Development

11.8 Covance

11.8.1 Covance Company Detail

11.8.2 Covance Business Overview

11.8.3 Covance Omics Based Clinical Trials Introduction

11.8.4 Covance Revenue in Omics Based Clinical Trials Business (2018-2023)

11.8.5 Covance Recent Development

11.9 Rebus Bio

11.9.1 Rebus Bio Company Detail

11.9.2 Rebus Bio Business Overview

11.9.3 Rebus Bio Omics Based Clinical Trials Introduction

11.9.4 Rebus Bio Revenue in Omics Based Clinical Trials Business (2018-2023)

11.9.5 Rebus Bio Recent Development

11.10 Novo Nordisk

11.10.1 Novo Nordisk Company Detail

11.10.2 Novo Nordisk Business Overview

11.10.3 Novo Nordisk Omics Based Clinical Trials Introduction

11.10.4 Novo Nordisk Revenue in Omics Based Clinical Trials Business (2018-2023)

11.10.5 Novo Nordisk Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Omics Based Clinical Trials Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Interventional Studies

    Table 3. Key Players of Observational Studies

    Table 4. Key Players of Expanded Access Studies

    Table 5. Global Omics Based Clinical Trials Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Omics Based Clinical Trials Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Omics Based Clinical Trials Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Omics Based Clinical Trials Market Share by Region (2018-2023)

    Table 9. Global Omics Based Clinical Trials Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Omics Based Clinical Trials Market Share by Region (2024-2029)

    Table 11. Omics Based Clinical Trials Market Trends

    Table 12. Omics Based Clinical Trials Market Drivers

    Table 13. Omics Based Clinical Trials Market Challenges

    Table 14. Omics Based Clinical Trials Market Restraints

    Table 15. Global Omics Based Clinical Trials Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Omics Based Clinical Trials Market Share by Players (2018-2023)

    Table 17. Global Top Omics Based Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Omics Based Clinical Trials as of 2022)

    Table 18. Ranking of Global Top Omics Based Clinical Trials Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Omics Based Clinical Trials Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Omics Based Clinical Trials Product Solution and Service

    Table 22. Date of Enter into Omics Based Clinical Trials Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Omics Based Clinical Trials Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Omics Based Clinical Trials Revenue Market Share by Type (2018-2023)

    Table 26. Global Omics Based Clinical Trials Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Omics Based Clinical Trials Revenue Market Share by Type (2024-2029)

    Table 28. Global Omics Based Clinical Trials Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Omics Based Clinical Trials Revenue Market Share by Application (2018-2023)

    Table 30. Global Omics Based Clinical Trials Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Omics Based Clinical Trials Revenue Market Share by Application (2024-2029)

    Table 32. North America Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Omics Based Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Omics Based Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Omics Based Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Omics Based Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Omics Based Clinical Trials Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Omics Based Clinical Trials Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Omics Based Clinical Trials Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Omics Based Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Omics Based Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Omics Based Clinical Trials Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Omics Based Clinical Trials Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Omics Based Clinical Trials Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Parexel International Corporation Company Detail

    Table 48. Parexel International Corporation Business Overview

    Table 49. Parexel International Corporation Omics Based Clinical Trials Product

    Table 50. Parexel International Corporation Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 51. Parexel International Corporation Recent Development

    Table 52. Pharmaceutical Product Development (PPD) Company Detail

    Table 53. Pharmaceutical Product Development (PPD) Business Overview

    Table 54. Pharmaceutical Product Development (PPD) Omics Based Clinical Trials Product

    Table 55. Pharmaceutical Product Development (PPD) Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 56. Pharmaceutical Product Development (PPD) Recent Development

    Table 57. Charles River Laboratory Company Detail

    Table 58. Charles River Laboratory Business Overview

    Table 59. Charles River Laboratory Omics Based Clinical Trials Product

    Table 60. Charles River Laboratory Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 61. Charles River Laboratory Recent Development

    Table 62. ICON plc Company Detail

    Table 63. ICON plc Business Overview

    Table 64. ICON plc Omics Based Clinical Trials Product

    Table 65. ICON plc Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 66. ICON plc Recent Development

    Table 67. SGS SA Company Detail

    Table 68. SGS SA Business Overview

    Table 69. SGS SA Omics Based Clinical Trials Product

    Table 70. SGS SA Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 71. SGS SA Recent Development

    Table 72. Eli Lilly and Company Company Detail

    Table 73. Eli Lilly and Company Business Overview

    Table 74. Eli Lilly and Company Omics Based Clinical Trials Product

    Table 75. Eli Lilly and Company Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 76. Eli Lilly and Company Recent Development

    Table 77. Pfizer Company Detail

    Table 78. Pfizer Business Overview

    Table 79. Pfizer Omics Based Clinical Trials Product

    Table 80. Pfizer Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 81. Pfizer Recent Development

    Table 82. Covance Company Detail

    Table 83. Covance Business Overview

    Table 84. Covance Omics Based Clinical Trials Product

    Table 85. Covance Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 86. Covance Recent Development

    Table 87. Rebus Bio Company Detail

    Table 88. Rebus Bio Business Overview

    Table 89. Rebus Bio Omics Based Clinical Trials Product

    Table 90. Rebus Bio Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 91. Rebus Bio Recent Development

    Table 92. Novo Nordisk Company Detail

    Table 93. Novo Nordisk Business Overview

    Table 94. Novo Nordisk Omics Based Clinical Trials Product

    Table 95. Novo Nordisk Revenue in Omics Based Clinical Trials Business (2018-2023) & (US$ Million)

    Table 96. Novo Nordisk Recent Development

    Table 97. Research Programs/Design for This Report

    Table 98. Key Data Information from Secondary Sources

    Table 99. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Omics Based Clinical Trials Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Omics Based Clinical Trials Market Share by Type: 2022 VS 2029

    Figure 3. Interventional Studies Features

    Figure 4. Observational Studies Features

    Figure 5. Expanded Access Studies Features

    Figure 6. Global Omics Based Clinical Trials Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Omics Based Clinical Trials Market Share by Application: 2022 VS 2029

    Figure 8. Oncology Case Studies

    Figure 9. Cardiology Case Studies

    Figure 10. Respiratory Diseases Case Studies

    Figure 11. Skin Diseases Case Studies

    Figure 12. CNS Diseases Case Studies

    Figure 13. Immunology Case Studies

    Figure 14. Genetic Diseases Case Studies

    Figure 15. Other Indications Case Studies

    Figure 16. Omics Based Clinical Trials Report Years Considered

    Figure 17. Global Omics Based Clinical Trials Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 18. Global Omics Based Clinical Trials Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 19. Global Omics Based Clinical Trials Market Share by Region: 2022 VS 2029

    Figure 20. Global Omics Based Clinical Trials Market Share by Players in 2022

    Figure 21. Global Top Omics Based Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Omics Based Clinical Trials as of 2022)

    Figure 22. The Top 10 and 5 Players Market Share by Omics Based Clinical Trials Revenue in 2022

    Figure 23. North America Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. North America Omics Based Clinical Trials Market Share by Country (2018-2029)

    Figure 25. United States Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Canada Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Europe Omics Based Clinical Trials Market Share by Country (2018-2029)

    Figure 29. Germany Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. France Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. U.K. Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Italy Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Russia Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Nordic Countries Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Asia-Pacific Omics Based Clinical Trials Market Share by Region (2018-2029)

    Figure 37. China Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Japan Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. South Korea Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Southeast Asia Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. India Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Australia Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Latin America Omics Based Clinical Trials Market Share by Country (2018-2029)

    Figure 45. Mexico Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Brazil Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Omics Based Clinical Trials Market Share by Country (2018-2029)

    Figure 49. Turkey Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia Omics Based Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Parexel International Corporation Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 52. Pharmaceutical Product Development (PPD) Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 53. Charles River Laboratory Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 54. ICON plc Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 55. SGS SA Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 56. Eli Lilly and Company Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 57. Pfizer Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 58. Covance Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 59. Rebus Bio Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 60. Novo Nordisk Revenue Growth Rate in Omics Based Clinical Trials Business (2018-2023)

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed